About Us
1919
Established
October 12
Milestones
¥881.9bn
Consolidated Revenue
FY2023
Company Outline
70%
Global Market Share*
*As of October 2022
Facts & Figures
38
Countries or Regions
*As of December 2022
Worldwide Office Locations
News
- Nov. 30, 2023 CorporateOlympus's Net-Zero Targets Approved by SBTi
- Oct. 31, 2023 CorporateOlympus and Terumo Announce Change in Form of Contract
- Oct. 03, 2023 CorporateOlympus Names Dr. John de Csepel as Chief Medical Officer
- Aug. 09, 2023 CorporateNotice of Stock Change of Olympus Terumo Biomaterials
- Jul. 20, 2023 CorporateOlympus to Launch Development Support Project in Kenya for the Diagnosis of Gastrointestinal Diseases